A Tidal Wave of Funding is Flowing into Biotech

by Jeff Brown
Casey Research

I remember it to this day…

It was June 2015.

A little-known financial asset was gaining the attention of a niche group of investors.

It promised independent financial transactions without the need for a “trusted” third party. It was being compared to gold and silver but was infinitely more transportable.

But even more interesting, the asset had just come off an incredible run, climbing more than 600% in just a few months of 2013.

Continue Reading at CaseyResearch.com…